Odd Terje B.
- Country
- Norway
- Department
- Onkologisk poliklinikk
Research Overview
- A Phase 3 Randomized Open-Label Study Comparing Sigvotatug Vedotin and Docetaxel in Adults with Previously Treated Non-Small Cell Lung Cancer
- Evaluation of Thoracic Radiotherapy Combined with Durvalumab and Chemotherapy in Extensive-Stage Small-Cell Lung Cancer: A Randomized Phase III Trial
- Phase 3 Randomized Study of Adjuvant mRNA-4157 and Pembrolizumab Versus Placebo and Pembrolizumab in Resected Stage II-IIIB Non-Small Cell Lung Cancer
Data & Insights
Has run more than one trial at 100 of 267 partner sites.
Specializations
Thoracic oncology and lung cancer
The investigator is strongly involved in clinical research on non-small cell lung cancer, including EGFR-mutated, HER2-mutated, and KRAS G12C-mutated disease, as well as small-cell lung cancer and advanced or metastatic thoracic malignancies.
- Immunotherapy combinations in advanced lung cancer
- Targeted therapy for molecularly defined NSCLC
- Perioperative and maintenance treatment strategies
Research activity also extends to treatment intensification, biomarker-driven therapy selection, and approaches aimed at improving disease control in treatment-resistant lung cancer.
Breast cancer and hormone receptor-driven disease
Clinical interests include HER2-positive and HER2-negative breast cancer, ER-positive advanced breast cancer, and triple-negative breast cancer, with emphasis on systemic treatment optimization in both early and advanced settings.
- HER2-directed treatment strategies
- Endocrine-based combinations
- Neoadjuvant and adjuvant therapy development
The investigator is also engaged in studies of treatment response, recurrence prevention, and novel antibody-based approaches in breast malignancies.
Inflammatory and autoimmune diseases
The research portfolio includes multiple sclerosis, Crohn's disease, and juvenile idiopathic arthritis, reflecting active involvement in immune-mediated disorders requiring long-term disease control.
- Multiple sclerosis disease-modifying therapy
- Inflammatory bowel disease treatment escalation
- Rheumatologic disease management in children and adolescents
Additional interest is seen in strategies that balance efficacy and treatment withdrawal in chronic immune-mediated conditions.
Cardiovascular, metabolic, and renal medicine
The investigator contributes to trials in chronic heart failure, atherosclerotic cardiovascular disease, type 2 diabetes, hypertension, and end-stage kidney disease, with a focus on cardiometabolic risk and organ protection.
- Heart failure outcomes
- Cardiovascular risk reduction
- Renal-associated inflammatory disease
Research activity also includes iron deficiency management and therapies targeting cardiovascular events in patients with complex comorbidity profiles.
Neurology, stroke, and acute care
Clinical trial involvement covers amyotrophic lateral sclerosis, acute ischemic stroke, and central retinal artery occlusion, highlighting interest in time-sensitive neurological and vascular conditions.
- Neurodegenerative disease therapy
- Thrombolytic treatment in acute vascular occlusion
- Emergency neurological intervention
The investigator also participates in studies aimed at improving outcomes after acute cerebrovascular and ophthalmic ischemic events.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.